Hepatocellular Carcinoma is the Leading Indication in Liver Transplant Registrants and Recipients in the United States

被引：0
|
作者：
Yang, Ju Dona [1 ]
Larson, Joseph J. [2 ]
Watt, Kymberly [1 ]
Allen, Alina M. [1 ]
Gores, Gregory J. [1 ]
Heimbach, Julie [3 ]
Roberts, Lewis R. [1 ]
Leise, Michael D. [1 ]
机构：
[1] Mayo Clin, Coll Med, Gastroenterol & Hepatol, Rochester, MN USA
[2] Mayo Clin, Biomed Stat & Informat, Rochester, MN USA
[3] Mayo Clin, Transplant Surg, Rochester, MN USA
来源：
HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1404
引用
收藏
页码：703A / 703A
页数：1
相关论文
共 50 条
  • [1] Sirolimus in Liver Transplant Recipients With Hepatocellular Carcinoma
    Grigg, Sam
    Gow, Paul
    Yeomans, Neville
    JOURNAL OF INVESTIGATIVE SURGERY, 2020, 33 (04) : 389 - 390
  • [2] DECREASING URGENCY OF LIVER TRANSPLANT CANDIDATES WITH HEPATOCELLULAR CARCINOMA IN THE UNITED STATES
    Kwong, Allison J.
    Ghaziani, T. Tahereh
    Mehta, Neil
    HEPATOLOGY, 2021, 74 : 631A - 631A
  • [3] Hepatocellular Carcinoma Is the Most Common Indication for Liver Transplantation and Placement on the Waitlist in the United States
    Yang, Ju Dong
    Larson, Joseph J.
    Watt, Kymberly D.
    Allen, Alina M.
    Wiesner, Russell H.
    Gores, Gregory J.
    Roberts, Lewis R.
    Heimbach, Julie A.
    Leise, Michael D.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2017, 15 (05) : 767 - +
  • [4] Nonviral liver disease is the leading indication for liver transplant in the United States in persons living with human immunodeficiency virus
    Campos-Varela, Isabel
    Dodge, Jennifer L.
    Terrault, Norah A.
    Brandman, Danielle
    Price, Jennifer C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 (09) : 3148 - 3156
  • [5] Strategies of Immunosuppression for Liver Transplant Recipients With Hepatocellular Carcinoma
    Castroagudin, J. F.
    Molina-Perez, E.
    Ferreiro-Iglesias, R.
    Varo-Perez, E.
    TRANSPLANTATION PROCEEDINGS, 2011, 43 (03) : 711 - 713
  • [6] Survival of liver transplant recipients with hemochromatosis in the United States
    Yu, Lei
    Ioannou, George N.
    GASTROENTEROLOGY, 2007, 133 (02) : 489 - 495
  • [7] Alcoholic liver disease surpasses hepatitis C virus in 2016 to become the leading indication for liver transplantation among adults without hepatocellular carcinoma in the United States
    Wang, J.
    Liu, B.
    Bhuket, T.
    Wong, R.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S369 - S369
  • [8] Patient outcomes in liver transplantation for hepatocellular carcinoma at a major transplant center in the United States
    Schafer, Michael
    Schafer, Daniel F.
    GASTROENTEROLOGY, 2008, 134 (04) : A804 - A804
  • [9] Down-staging of hepatocellular carcinoma tumors at liver transplant centers in the United States
    Wong, She-Yan
    Halegoua-De Marzio, Dina
    Civan, Jesse M.
    HEPATOLOGY, 2014, 60 : 888A - 889A
  • [10] NASH is the Leading Cause of Hepatocellular Carcinoma in Liver Transplant Candidates
    Koh, Jia Hong
    Ng, Cheng Han
    Nah, Benjamin
    Tan, Darren Jun Hao
    Loomba, Rohit
    Huang, Daniel Q.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 22 (01) : 197 - 199
12345